TIGIT and neoplasm: To investigate potential tumor cell‐induced functional alterations in T cells, we performed CITRUS [29] analysis using expression of eight markers including checkpoint receptor TIGIT, activation and differentiation markers (phospho‐STAT1, HLA‐DR, CD38, CD69, Ki‐67, CD28), and marker of apoptosis (cleaved‐caspase 3).